Table: Garna Biosciences -Q1 group results

Carna Biosciences

12/05/2020 07:30

May 12 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2020        Mar 31, 2019     Dec 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            335 mln             169 mln           1.04     
                 (+97.1 pct)         (-19.5 pct)      (-67.7 pct) 
  Operating     loss 165 mln        loss 233 mln       loss 1.78  
  Recurring     loss 168 mln        loss 235 mln       loss 1.79  
  Net           loss 184 mln        loss 236 mln       loss 1.82  
  EPS          loss 15.25 yen      loss 23.16 yen     156.45 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T